Cover Image
Market Research Report

North America Smart Inhalers Market Forecast 2019-2028

Published by Inkwood Research Product code 945451
Published Content info 124 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Smart Inhalers Market Forecast 2019-2028
Published: June 30, 2020 Content info: 124 Pages
Description

KEY FINDINGS

The North America smart inhalers market is predicted to register a CAGR of 31.01% over the projected period, 2019-2028. Technological developments, as well as competition among important pharmaceutical players, are augmenting market growth in the region.

MARKET INSIGHTS

The North America smart inhalers market growth is assessed through the countries of the United States and Canada. In Canada, total healthcare spending was estimated to reach USD xx billion or USD xx per person. It exhibits about 11.3% of the country's GDP. In Canada, the primary factor boosting the growth of respiratory devices is the surging incidence of respiratory diseases. The patients suffering from COPD in the age group of 50 to 64 years were 261,000 in 2016 as per the statistics of Canada. It increased to 314,400 the next year. According to the Ontario Lung Association, asthma accounts for about 80% of chronic respiratory diseases in Canada. Some of the renowned companies established in Canada supplying nebulizers are PARI, MedQuip, Sunset, Respironics, among others. The prices range from low CAD 25 to CAD 190, based on the severity of diseases. The MDI is increasingly advised in schools and colleges among children, due to its better efficiency, rapid administration, and fewer side effects. However, the nebulizer is expected to be preferred over MDI in long term care, as it is less expensive and easily available. The mesh nebulization technology is becoming popular in various hospitals across Canada, leading to cost savings and superior performance, in turn, fueling market growth.

COMPETITIVE INSIGHTS

Some of the well-established companies functioning in the market are Teva Pharmaceutical Industries Limited, 3M Company, Agilent Technologies, Inc, Opko Health Inc, Koninklijke Philips N.V., etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32367

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. RISE IN AIR POLLUTION
    • 3.2.2. HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES
    • 3.2.3. SURGING INDOOR AIR POLLUTANTS
    • 3.2.4. RISING GERIATRIC POPULATION
    • 3.2.5. GROWING PREVALENCE OF COPD AND ASTHMA
  • 3.3. KEY RESTRAINTS
    • 3.3.1. DATA SECURITY CONCERN HAMPERS THE MARKET
    • 3.3.2. HIGH COST OF ASTHMA AND COPD TREATMENT

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. EVOLUTION OF SMART INHALERS
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. SMART INHALERS
  • 5.2. SMART NEBULIZER
    • 5.2.1. TYPES OF NEBULIZER (QUALITATIVE)
      • 5.2.1.1. PNEUMATIC NEBULIZER
      • 5.2.1.2. ULTRASONIC NEBULIZER
      • 5.2.1.3. MESH NEBULIZER
    • 5.2.2. NEBULIZER BY PORTABILITY (QUALITATIVE)
      • 5.2.2.1. TABLETOP NEBULIZER
      • 5.2.2.2. PORTABLE NEBULIZER
    • 5.2.3. NEBULIZER BY SALES CHANNEL (QUALITATIVE)
      • 5.2.3.1. DIRECT PURCHASE
      • 5.2.3.2. ONLINE PURCHASE

6. MARKET BY INDICATION

  • 6.1. ASTHMA
  • 6.2. COPD

7. MARKET BY DISTRIBUTION CHANNEL

  • 7.1. HOSPITAL
  • 7.2. PHARMACY

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. THE UNITED STATES
    • 8.1.2. CANADA

9. COMPANY PROFILES

  • 9.1. 3M COMPANY
  • 9.2. ADHERIUM LIMITED
  • 9.3. AGILENT TECHNOLOGIES INC
  • 9.4. ASTRAZENECA PLC
  • 9.5. BOEHRINGER INGELHEIM GMBH
  • 9.6. COHERO HEALTH INC
  • 9.7. GLAXOSMITHKLINE PLC
  • 9.8. KONINKLIJKE PHILIPS N.V
  • 9.9. NOVARTIS AG
  • 9.10. OPKO HEALTH INC
  • 9.11. RESMED INC (PROPELLER HEALTH)
  • 9.12. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • 9.13. VECTURA GROUP PLC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SMART INHALERS
  • TABLE 2: NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 3: NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 4: NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 5: NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 6: NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 7: NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
  • TABLE 8: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
  • TABLE 9: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: NORTH AMERICA SMART INHALERS MARKET, BY PRODUCT, IN 2019
  • FIGURE 6: NORTH AMERICA SMART INHALERS MARKET, BY SMART INHALERS, 2019-2028 (IN $ THOUSAND)
  • FIGURE 7: NORTH AMERICA SMART INHALERS MARKET, BY SMART NEBULIZER, 2019-2028 (IN $ THOUSAND)
  • FIGURE 8: NORTH AMERICA SMART INHALERS MARKET, BY INDICATION, IN 2019
  • FIGURE 9: NORTH AMERICA SMART INHALERS MARKET, BY ASTHMA, 2019-2028 (IN $ THOUSAND)
  • FIGURE 10: NORTH AMERICA SMART INHALERS MARKET, BY COPD, 2019-2028 (IN $ THOUSAND)
  • FIGURE 11: NORTH AMERICA SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, IN 2019
  • FIGURE 12: NORTH AMERICA SMART INHALERS MARKET, BY HOSPITAL, 2019-2028 (IN $ THOUSAND)
  • FIGURE 13: NORTH AMERICA SMART INHALERS MARKET, BY PHARMACY, 2019-2028 (IN $ THOUSAND)
  • FIGURE 14: NORTH AMERICA SMART INHALERS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 15: THE UNITED STATES SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
  • FIGURE 16: CANADA SMART INHALERS MARKET, 2019-2028 (IN $ THOUSAND)
Back to Top